Sotera Health’s $1.2 Billion Initial Public Offering

Simpson Thacher represented the underwriters, led by J.P. Morgan Securities LLC, Credit Suisse (USA) LLC, Goldman Sachs & Co LLC and Jefferies LLC, in the offering.

Sotera Health Company executed the initial public offering of 53,590,000 shares of its common stock, which raised approximately $1.2 billion in gross proceeds. The initial public offering closed on November 24, 2020.

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses–Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

The Simpson Thacher team for this transaction included Art Robinson (Picture), Jean Park, Kirsten Harmon, Arielle Trapp and Simone Worthy (Capital Markets); Vanessa Burrows (Healthcare); Mike Isby (Environmental); Andrew Blau and Pasco Struhs (Executive Compensation and Employee Benefits); Jennifer Nadborny and Joia Lee (Public Company Advisory Practice); Jonathan Cantor (Tax); Andrew Pagliughi (FINRA & Blue Sky); and Alysha Sekhon (IP).

Involved fees earner: Andrew Blau – Simpson Thacher & Bartlett; Vanessa Burrows – Simpson Thacher & Bartlett; Jonathan Cantor – Simpson Thacher & Bartlett; Kirsten Harmon – Simpson Thacher & Bartlett; Michael Isby – Simpson Thacher & Bartlett; Joia Lee – Simpson Thacher & Bartlett; Jennifer Nadborny – Simpson Thacher & Bartlett; Andrew Pagliughi – Simpson Thacher & Bartlett; Jean Park – Simpson Thacher & Bartlett; Arthur Robinson – Simpson Thacher & Bartlett; Alysha Sekhon – Simpson Thacher & Bartlett; Pasco Struhs – Simpson Thacher & Bartlett; Arielle Trapp – Simpson Thacher & Bartlett; Simone Worthy – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: Credit Suisse; Goldman Sachs & Co.; J.P. Morgan Securities LLC; Jefferies;

Author: Ambrogio Visconti